- Category
- Small (2023-24)
- Udyam number
- UDYAM-KR-03-0040590

About Clevergene Biocorp Private Limited
Data last updated:
Clevergene Biocorp Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 04 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73200KA2013PTC069488. Its GSTIN is 29AAFCC2778K1Z5 (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.72 Lakh. It is led by directors including Antony Thomas and Tony Jose.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Ground Floor & 1st Floor Site No. 617 5th Main Ombr Layout Banaswadi, Bengaluru, Karnataka, India – 560043.
As per the financials filed for FY 2022, the company reported a revenue of ₹9.97 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net loss of ₹1.74 Cr (net margin -17.4%) and EBITDA of ₹1.14 Cr (EBITDA margin 11.5%). Revenue has grown at a compounded annual rate (CAGR) of 60% over three years and 108% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: The Gene Lab and Clevergene. Court records list 32 cases involving the company, including 2 filed by the company and 30 filed against it; 16 cases are pending. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.09 Cr; the latest was in February 2022. The company has 4 MSME Form 1 returns on record between 2019 and 2022, listing 32 overdue payments to 8 micro and small suppliers.
Clevergene Biocorp Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0040590). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website clevergene.in.
Company details
Recognitions & Rankings of Clevergene Biocorp
Contact details
Clevergene Biocorp Private Limited's registered office is in Bengaluru, Karnataka. Its website is clevergene.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressGround Floor & 1st Floor Site No. 617 5th Main Ombr Layout Banaswadi, Bengaluru, Karnataka, India – 560043
- IndustryLife Sciences, Biotechnology
To see the full contact details of Clevergene Biocorp Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Clevergene Biocorp operates two associated brands: The Gene Lab and Clevergene. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of RT-PCR testing services | thegenelab.com | |
| Genomic-based bioinformatics solutions are provided for research and translational sciences. | clevergene.in |
Business activity
The main business activity of Clevergene Biocorp is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Clevergene Biocorp Private Limited, buy the company report.
Financials of Clevergene Biocorp Private Limited
FY 2022 filings availableClevergene Biocorp Private Limited reported revenue of ₹9.97 Cr (up 39% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 108% over five years, including 39% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹9.97 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.14 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.74 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.5% | ||||
| Net Profit Margin | -17.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Clevergene Biocorp Private Limited, buy the company report.
Board of directors of Clevergene Biocorp Private Limited
Clevergene Biocorp has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Antony Thomas | Director | 16 May 2016 | 10 Years 5 Months | Current |
| Tony Jose Also directs: Precision Health Innovations Private Limited | Director | 04 Jun 2013 | 13 Years 4 Months | Current |
| Ria Dutta | Director | 10 Nov 2025 | 0 Years 11 Months | Current |
Auditor
Clevergene Biocorp Private Limited is audited by L.K. Kejriwal & Co for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| L.K. Kejriwal & Co | FY 2022 | 001368C |
Shareholding
The shareholding of Clevergene Biocorp Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Clevergene Biocorp Private Limited, buy the company report.
Deals & funding
Clevergene Biocorp Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.09 Cr; the latest was in February 2022.
Deals on record (3 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2022 | Secondary share transfer | Undisclosed | Seller: an individual |
| Jan 2020 | Funding round | ₹4.49 Cr | Investors: Auxano, an individual |
| Jun 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
To see the full deal history of Clevergene Biocorp Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Clevergene Biocorp Private Limited has 32 court cases on record: 2 filed by Clevergene Biocorp, 30 filed against it. 16 cases are pending and 16 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 30 | 30 | 16 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 32)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Court case (Com.EX.) | Filed against the company by M/S Strive Biocorp Pvt Ltd | Pending |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by M/S. RBL Bank Ltd | Pending |
| District court, BENGALURU, Karnataka | Court case (Com.EX.) | Filed against the company by M/S SMFG India Credit Company Limited | Pending |
| District court, BENGALURU, Karnataka | Court case (Com.EX.) | Filed against the company by Lifecell International Private Limited | Pending |
| District court, Jaipur Metro II, Rajasthan | Criminal case | Filed against the company by SMFG India Credit Company Ltd | Pending |
To see the full case history of Clevergene Biocorp Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Clevergene Biocorp Private Limited has 4 MSME Form 1 returns on record between 2019 and 2022, listing 32 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Aic Enterprises Private Limited | |||
| Medisave Health and Lifestyle Private Limited | |||
| Bionova Supplies | |||
| Criticalog India Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Clevergene Biocorp Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Clevergene Biocorp Private Limited has a workforce of 2 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Clevergene Biocorp has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAFCC2778K1Z5 | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Clevergene Biocorp Private Limited, buy the company report.
Recent activity
Clevergene Biocorp Private Limited has 6 board changes on record since 2013: 3 appointments and 3 cessations. The latest: Ria Dutta was appointed as Director on 10 Nov 2025.
News
Frequently asked questions
Clevergene Biocorp is an active private limited company based in Bengaluru, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 04 June 2013 (13+ years old) and is registered under CIN U73200KA2013PTC069488.
Clevergene Biocorp has 3 current directors:
- Antony Thomas - Director
- Tony Jose - Director
- Ria Dutta - Director
The latest financial statements of Clevergene Biocorp on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
The GSTIN of Clevergene Biocorp is 29AAFCC2778K1Z5, registered in Karnataka.
The CIN (Corporate Identification Number) of Clevergene Biocorp is U73200KA2013PTC069488. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clevergene Biocorp has 32 court cases on record: 2 filed by the company and 30 filed against it. 16 are pending. Most are in the district courts.
Clevergene Biocorp was incorporated on 04 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.
Clevergene Biocorp has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.09 Cr; the latest was in February 2022.
Ria Dutta was appointed as Director on 10 Nov 2025. Rajasekhara Reddy Ravuri ceased to be Additional Director on 15 Oct 2021. Dhruv Prasher ceased to be Director on 30 Sep 2021. Clevergene Biocorp has 6 board changes on record in total.
Yes, Clevergene Biocorp is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0040590).
Clevergene Biocorp has 4 MSME Form 1 returns on record between 2019 and 2022, listing 32 overdue payments to 8 micro and small suppliers. The latest return was filed on 01 Jun 2022.